Medical Health & Life Science Research News

Learn details of the reviews pipeline therapeutics for indoleamine 2,3 dioxygenase 1

Medical Market Research

Indoleamine 2,3 Dioxygenase 1 - Pipeline Review, H1 2018, outlays comprehensive information on the Indoleamine 2,3 Dioxygenase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Indoleamine-pyrrole 2, 3-dioxygenase 1 is a heme-containing enzyme encoded by the IDO1 gene. This enzyme acts on multiple tryptophan substrates including D-tryptophan, L-tryptophan, 5-hydroxy-tryptophan, tryptamine, and serotonin.

complete report available at: www.themarketreports.com/report/in…e-review-h1-2018

Scope

  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Indoleamine 2,3 Dioxygenase 1 targeted therapeutics and enlists all their major and minor projects
  • The report assesses Indoleamine 2,3 Dioxygenase 1 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Indoleamine 2,3 Dioxygenase 1 targeted therapeutics

Access complete report at: www.themarketreports.com/report/1069379

Companies Mentioned

  • BeiGene Ltd
  • BirchBioMed Inc
  • Bristol-Myers Squibb Co
  • CanBas Co Ltd
  • Eli Lilly and Co
  • Ensemble Therapeutics Corp
  • Hoffmann-La Roche Ltd
  • Incyte Corp
  • Innovent Biologics Inc
  • IO Biotech ApS
  • iTeos Therapeutics SA
  • Jiangsu Hengrui Medicine Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Luye Pharma Group Ltd
  • Netherlands Translational Research Center BV
  • NewLink Genetics Corp
  • Regen BioPharma Inc
  • Tempest Therapeutics Inc

inquire about this report at: www.themarketreports.com/report/as…ur-query/1069379

News From

The Market Reports - Industry & Market Reports at its BESTThe Market Reports
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
This email address is being protected from spambots. You need JavaScript enabled to view it.